Advisory Commission of Childhood Vaccines; Request for Nominations for Voting Members, 23873 [E9-11928]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 97 / Thursday, May 21, 2009 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Commission of Childhood
Vaccines; Request for Nominations for
Voting Members
AGENCY: Health Resources and Services
Administration, HHS.
ACTION: Notice.
SUMMARY: The Health Resources and
Services Administration (HRSA) is
requesting nominations to fill three
vacancies on the Advisory Commission
on Childhood Vaccines (ACCV). The
ACCV was established by Title XXI of
the Public Health Service Act (the Act),
as enacted by Public Law (Pub. L.) 99–
660 and as subsequently amended, and
advises the Secretary of Health and
Human Services (the Secretary) on
issues related to implementation of the
National Vaccine Injury Compensation
Program (VICP).
DATES: The agency must receive
nominations on or before June 22, 2009.
ADDRESSES: All nominations are to be
submitted to the Director, Division of
Vaccine Injury Compensation,
Healthcare Systems Bureau (HSB),
HRSA, Parklawn Building, Room 11C–
26, 5600 Fishers Lane, Rockville,
Maryland 20857.
FOR FURTHER INFORMATION CONTACT: Ms.
Michelle Herzog, Principal Staff Liaison,
Policy Analysis Branch, Division of
Vaccine Injury Compensation, HSB,
HRSA at (301) 443–0650 or e-mail:
mherzog@hrsa.gov.
Under the
authorities that established the ACCV,
the Federal Advisory Committee Act of
October 6, 1972 (Pub. L. 92–463) and
section 2119 of the Act, 42 U.S.C.
300aa–19, as added by Public Law 99–
660 and amended, HRSA is requesting
nominations for three voting members
of the ACCV.
The ACCV advises the Secretary on
the implementation of the VICP. The
activities of the ACCV include:
recommending changes in the Vaccine
Injury Table at its own initiative or as
the result of the filing of a petition;
advising the Secretary in implementing
section 2127 regarding the need for
childhood vaccination products that
result in fewer or no significant adverse
reactions; surveying Federal, State, and
local programs and activities related to
gathering information on injuries
associated with the administration of
childhood vaccines, including the
adverse reaction reporting requirements
dwashington3 on PROD1PC60 with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Nov<24>2008
13:08 May 20, 2009
Jkt 217001
of section 2125(b); advising the
Secretary on the methods of obtaining,
compiling, publishing, and using
credible data related to the frequency
and severity of adverse reactions
associated with childhood vaccines;
consulting on the development or
revision of the Vaccine Information
Statements and recommending to the
Director of the National Vaccine
Program that vaccine safety research be
conducted on various vaccine injuries.
The ACCV consists of nine voting
members appointed by the Secretary as
follows: (1) Three health professionals,
who are not employees of the United
States Government and have expertise
in the health care of children, and the
epidemiology, etiology, and prevention
of childhood diseases, and the adverse
reactions associated with vaccines, at
least two shall be pediatricians; (2) three
members from the general public, at
least two shall be legal representatives
(parents or guardians) of children who
have suffered a vaccine-related injury or
death; and (3) three attorneys, at least
one shall be an attorney whose specialty
includes representation of persons who
have suffered a vaccine-related injury or
death, and one shall be an attorney
whose specialty includes representation
of vaccine manufacturers. In addition,
the Director of the National Institutes of
Health, the Assistant Secretary for
Health, the Director of the Centers for
Disease Control and Prevention, and the
Commissioner of the Food and Drug
Administration (or the designees of such
officials) serve as nonvoting ex officio
members.
Specifically, HRSA is requesting
nominations for three voting members
of the ACCV representing: (1) A health
professional, who has expertise in the
health care of children; and the
epidemiology, etiology, and prevention
of childhood diseases; (2) an attorney
whose specialty includes representation
of a vaccine manufacturer; and (3) a
member of the general public. Nominees
will be invited to serve a 3-year term
beginning January 1, 2010, and ending
December 31, 2012.
Interested persons may nominate one
or more qualified persons for
membership on the ACCV. Nominations
shall state that the nominee is willing to
serve as a member of the ACCV and
appears to have no conflict of interest
that would preclude the ACCV
membership. Potential candidates will
be asked to provide detailed information
concerning consultancies, research
grants, or contracts to permit evaluation
of possible sources of conflicts of
interest. A curriculum vitae or resume
should be submitted with the
nomination.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
23873
The Department of Health and Human
Services has special interest in assuring
that women, minority groups, and the
physically disabled are adequately
represented on advisory committees;
and therefore, extends particular
encouragement to nominations for
appropriately qualified female,
minority, or disabled candidates.
Dated: May 15, 2009.
Alexandra Huttinger,
Director, Division of Policy Review and
Coordination.
[FR Doc. E9–11928 Filed 5–20–09; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Family Youth and Services Bureau
AGENCY: Family Youth And Services
Bureau, ACF, DHHS.
ACTION: Notice to Award a Single-Source
Replacement Grant.
CFDA#: 93.616.
Legislative Authority: Section 439 of
the Social Security Act, as amended by
the Child and Family Services
Improvement Act of 2006 (Pub. L. 109–
288)
Amount of Award: $292,000.
Project Period: April 1, 2009–
September 29, 2010.
SUMMARY: The Family and Youth
Services Bureau (FYSB) awarded a
Mentoring Children of Prisoners grant
(Grant No. 90CV0343) to Prevent Child
Abuse California of North Highlands,
CA on September 30, 2007. On October
31, 2008, Prevent Child Abuse
California submitted a letter
relinquishing their grant. Amador
Tuolumne Community Action Agency
of Jackson, CA, an eligible non-profit
organization, submitted their letter
along with their grant application
requesting approval as the replacement
grantee for the Mentoring Children of
Prisoners grant. FYSB has received and
reviewed the application from Amador
Tuolumne Community Action Agency.
Upon finding that the proposed project
will be able to carry out objectives
originally intended to be completed by
Prevent Child Abuse California, this
organization has been awarded funds in
the amount of $292,000 as the
permanent successor grantee.
Amador Tuolumne Community
Action Agency will continue through a
community-based approach to work
toward the goal of creating high-quality,
one-to-one lasting mentoring
E:\FR\FM\21MYN1.SGM
21MYN1
]]>Agencies
[Federal Register Volume 74, Number 97 (Thursday, May 21, 2009)]
[Notices]
[Page 23873]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-11928]
[[Page 23873]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Commission of Childhood Vaccines; Request for
Nominations for Voting Members
AGENCY: Health Resources and Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Health Resources and Services Administration (HRSA) is
requesting nominations to fill three vacancies on the Advisory
Commission on Childhood Vaccines (ACCV). The ACCV was established by
Title XXI of the Public Health Service Act (the Act), as enacted by
Public Law (Pub. L.) 99-660 and as subsequently amended, and advises
the Secretary of Health and Human Services (the Secretary) on issues
related to implementation of the National Vaccine Injury Compensation
Program (VICP).
DATES: The agency must receive nominations on or before June 22, 2009.
ADDRESSES: All nominations are to be submitted to the Director,
Division of Vaccine Injury Compensation, Healthcare Systems Bureau
(HSB), HRSA, Parklawn Building, Room 11C-26, 5600 Fishers Lane,
Rockville, Maryland 20857.
FOR FURTHER INFORMATION CONTACT: Ms. Michelle Herzog, Principal Staff
Liaison, Policy Analysis Branch, Division of Vaccine Injury
Compensation, HSB, HRSA at (301) 443-0650 or e-mail: mherzog@hrsa.gov.
SUPPLEMENTARY INFORMATION: Under the authorities that established the
ACCV, the Federal Advisory Committee Act of October 6, 1972 (Pub. L.
92-463) and section 2119 of the Act, 42 U.S.C. 300aa-19, as added by
Public Law 99-660 and amended, HRSA is requesting nominations for three
voting members of the ACCV.
The ACCV advises the Secretary on the implementation of the VICP.
The activities of the ACCV include: recommending changes in the Vaccine
Injury Table at its own initiative or as the result of the filing of a
petition; advising the Secretary in implementing section 2127 regarding
the need for childhood vaccination products that result in fewer or no
significant adverse reactions; surveying Federal, State, and local
programs and activities related to gathering information on injuries
associated with the administration of childhood vaccines, including the
adverse reaction reporting requirements of section 2125(b); advising
the Secretary on the methods of obtaining, compiling, publishing, and
using credible data related to the frequency and severity of adverse
reactions associated with childhood vaccines; consulting on the
development or revision of the Vaccine Information Statements and
recommending to the Director of the National Vaccine Program that
vaccine safety research be conducted on various vaccine injuries.
The ACCV consists of nine voting members appointed by the Secretary
as follows: (1) Three health professionals, who are not employees of
the United States Government and have expertise in the health care of
children, and the epidemiology, etiology, and prevention of childhood
diseases, and the adverse reactions associated with vaccines, at least
two shall be pediatricians; (2) three members from the general public,
at least two shall be legal representatives (parents or guardians) of
children who have suffered a vaccine-related injury or death; and (3)
three attorneys, at least one shall be an attorney whose specialty
includes representation of persons who have suffered a vaccine-related
injury or death, and one shall be an attorney whose specialty includes
representation of vaccine manufacturers. In addition, the Director of
the National Institutes of Health, the Assistant Secretary for Health,
the Director of the Centers for Disease Control and Prevention, and the
Commissioner of the Food and Drug Administration (or the designees of
such officials) serve as nonvoting ex officio members.
Specifically, HRSA is requesting nominations for three voting
members of the ACCV representing: (1) A health professional, who has
expertise in the health care of children; and the epidemiology,
etiology, and prevention of childhood diseases; (2) an attorney whose
specialty includes representation of a vaccine manufacturer; and (3) a
member of the general public. Nominees will be invited to serve a 3-
year term beginning January 1, 2010, and ending December 31, 2012.
Interested persons may nominate one or more qualified persons for
membership on the ACCV. Nominations shall state that the nominee is
willing to serve as a member of the ACCV and appears to have no
conflict of interest that would preclude the ACCV membership. Potential
candidates will be asked to provide detailed information concerning
consultancies, research grants, or contracts to permit evaluation of
possible sources of conflicts of interest. A curriculum vitae or resume
should be submitted with the nomination.
The Department of Health and Human Services has special interest in
assuring that women, minority groups, and the physically disabled are
adequately represented on advisory committees; and therefore, extends
particular encouragement to nominations for appropriately qualified
female, minority, or disabled candidates.
Dated: May 15, 2009.
Alexandra Huttinger,
Director, Division of Policy Review and Coordination.
[FR Doc. E9-11928 Filed 5-20-09; 8:45 am]
BILLING CODE 4165-15-P
